Show simple item record

dc.contributor.authorSAURÍ, Lluís
dc.date.accessioned2012-02-28T12:43:53Z
dc.date.available2012-02-28T12:43:53Z
dc.date.issued2012
dc.identifier.citationFlorence : European University Institute, 2012en
dc.identifier.urihttps://hdl.handle.net/1814/20696
dc.descriptionDefence date: 15 February 2012en
dc.descriptionExamining Board: Prof. Elena Carletti, European University Institute; Prof. Pierre-Yves Geoffard, Paris-Jourdan Sciences Economiques; Prof. Massimo Motta, Supervisor, Universitat Pompeu Fabra; Prof. Damien Neven, European Commission and University of Geneva.
dc.description.abstractRegulation in pharmaceutical markets is pervasive in most countries, especially in Europe. The nature of existing regulations is diverse, as they serve a number of purposes: guaranteeing safety, efficacy and security of drug usage; but also ensuring patients access to treatment, preserving affordability and fostering pharmaceutical innovation. A number of regulatory interventions are purposely designed to bring about more efficient pharmaceutical markets. These interventions are ultimately intended to increase welfare for patients today and patients tomorrow. Welfare today requires ensuring patients access to existing pharmacological treatment at an affordable cost. Welfare tomorrow requires ensuring a continued effort on research and development to produce pharmaceutical innovations that respond to currently unmet medical needs. The chapters of this thesis focus on a number of regulatory interventions that attract notable attention due to their effect on access, affordability and innovation. These include the regulation of pharmaceutical parallel trade, direct-to-consumer advertising of prescription drugs and off-patent pharmaceutical markets. By assessing the impact of public interventions on market outcomes and patients welfare, this thesis aims at contributing to the debate about optimal regulation of pharmaceutical markets.en
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.publisherEuropean University Instituteen
dc.relation.ispartofseriesEUIen
dc.relation.ispartofseriesECOen
dc.relation.ispartofseriesPhD Thesisen
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleAn Economic Analysis of the Regulation of Pharmaceutical Marketsen
dc.typeThesisen
dc.identifier.doi10.2870/37014
dc.neeo.contributorSAURÍ|Lluís|aut|
eui.subscribe.skiptrue


Files associated with this item

Icon

This item appears in the following Collection(s)

Show simple item record